What Needle Gauge to Use for Peptides, TRT, and GLP-1 Injections

The gauge number tells you the needle's outer diameter (counterintuitively, higher gauge = thinner needle). For subcutaneous injections, which cover most peptides and GLP-1 medications, you want a high gauge (fine needle). For intramuscular injections, you need a lower gauge (thicker needle) with more length to reach the muscle.

Here is the full reference.

Quick Reference: Needle Gauge by Compound Type

SubQ vs IM: Which Route and Why

Subcutaneous (SubQ): into the fat layer just under the skin. The dominant route for:

• All GLP-1 medications (semaglutide, tirzepatide)
• Most peptides (BPC-157, TB-500, GHK-Cu, PT-141, HCG)
• Testosterone for microdosing and frequent injection protocols

SubQ is easier to self-administer, less painful, and you're not going anywhere near a nerve or blood vessel, all good reasons why most peptide users default to it.

Intramuscular (IM): into the muscle, typically glute, ventroglute, or thigh. Used for:

• Higher-volume testosterone preparations
• Nebido (1000mg in 4mL; too viscous and high-volume for SubQ)
• When the prescriber specifies IM (common in clinic-administered protocols)

High-volume oil-based injectables like Nebido (4mL per injection) and Sustanon at higher volumes are designed for IM. Trying to SubQ 4mL of oil at once is a bad time. If the compound comes in an oil vehicle at higher volumes, IM is the intended route. Lower-volume water-based peptides work fine SubQ.

Ready to track your protocol?

• Smart reminders so you never miss a dose
• Progress tracking with photos and weight
• Medication level curves for every compound

Get Regimen Free

What Gauge Actually Means

The gauge system is counterintuitive. A 29G needle is thinner than a 25G needle. Here's the diameter reference:

For most SubQ peptide and testosterone injections, 27-29G in a ½" insulin syringe is the standard. For GLP-1 pen users, the pen handles the needle for you (29-32G is built in).

Syringe Choice by Volume

Needle gauge and syringe barrel are separate choices. The syringe determines how much you can draw up; the needle determines how it goes in.

For testosterone cypionate at 100mg/mL, a 200mg dose = 2mL, so use a 3mL syringe. At 200mg/mL concentration, a 200mg dose = 1mL, so a 1mL syringe works.

For peptide injections of 200-500mcg in a typical reconstitution volume, a 0.3mL or 0.5mL insulin syringe handles the volume easily.

Common Questions

What gauge needle for testosterone subcutaneous injections?
27-29G in a ½" (0.5") insulin syringe is the standard for SubQ testosterone. Most people use a 29G 0.5mL insulin syringe for daily or twice-weekly microdosing protocols.

What needle for BPC-157?
A 29G ½" insulin syringe (0.5mL or 1mL). Draw up through the same needle you inject with; the volume is low enough that this works fine. Some people use a larger drawing needle then swap to a finer injection needle.

Can I use the same needle for drawing up and injecting?
For peptides and GLP-1s: yes, the volumes are small and the fine gauge draws up adequately. For viscous oils (testosterone cypionate, Nebido): draw with an 18-21G needle, then swap to your injection needle (23-29G depending on route). The higher-gauge needle will be slower to draw through but goes in much more comfortably.

What gauge for intramuscular testosterone?
21-23G for the glute; 23-25G for the ventroglute (the preferred and lower-risk IM site). Length should be 1-1.5" to reach the muscle through typical adipose tissue.

Does needle gauge affect absorption?
No evidence that gauge significantly affects absorption rate for SubQ or IM injections in the therapeutic volume range. Route matters more than gauge.

Tracking Your Protocol

When you change needle gauge or injection route, log it. A switch from IM to SubQ on the same dose often produces a noticeably different absorption curve: SubQ tends to be slower and more stable. Logging the change as a protocol event in Regimen lets the pattern engine correlate any subjective changes (energy, injection site soreness, absorption consistency) against the route change.

This article is for informational purposes only and does not constitute medical advice. Discuss all treatment decisions with your healthcare provider.